Cambrex Expands Snapdragon Chemistry Facility to Boost Peptide Therapy Manufacturing
Cambrex, a leading global contract development and manufacturing organization (CDMO), announced the expansion of its Snapdragon Chemistry API facility in Waltham, Massachusetts, strengthening its capabilities in peptide drug development and manufacturing.
Snapdragon Chemistry Facility | 26/08/2025 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy